Advertisement
UK markets closed

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     

  • CRUDE OIL

    82.54
    -0.27 (-0.33%)
     

  • GOLD FUTURES

    2,339.40
    +1.00 (+0.04%)
     

  • DOW

    37,981.53
    -479.39 (-1.25%)
     

  • Bitcoin GBP

    51,350.20
    -356.31 (-0.69%)
     

  • CMC Crypto 200

    1,386.10
    +3.53 (+0.26%)
     

  • NASDAQ Composite

    15,523.98
    -188.77 (-1.20%)
     

  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     
Stocks:

Trending tickers

Microsoft, Alphabet, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's

Company News For May 17, 2018

Zacks Equity Research
Updated
Texas Capital (TCBI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Twenty-First Century Fox Inc.’s FOXA shares gained 0.7% after the company settled lawsuits with 18 former employees of the Fox News Channel, who had sued the company over alleged racial and gender discrimination

  • IQVIA Holdings Inc. IQV decreased 2.9% after the FDA raised serious concerns with the company’s data related to controlled substances like prescription fentanyl

  • Abaxis Inc.’s ABAX shares jumped 16.2 after animal health company Zoetis Inc. ZTS agreed to buy it for $1.9 billion in cash

  • Shares of Teva Pharmaceutical Industries Ltd. TEVA rose 2.9% after Warren Buffet’s Berkshire Hathaway Inc. BRK.B more than doubled its investment in the company


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Berkshire Hathaway Inc. (BRK.B) : Free Stock Analysis Report
 
Abaxis,Inc. (ABAX) : Free Stock Analysis Report
 
Zoetis Inc. (ZTS) : Free Stock Analysis Report
 
Teva Pharmaceutical Industries Ltd. (TEVA) : Free Stock Analysis Report
 
Twenty-First Century Fox, Inc. (FOXA) : Free Stock Analysis Report
 
Quintiles Transitional Holdings Inc. (IQV) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research